Free Trial

Strategy (MSTR) 10K Form and Latest SEC Filings 2026

Strategy logo
$194.92 +7.33 (+3.91%)
As of 03:30 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Strategy SEC Filings & Recent Activity

Strategy (NASDAQ:MSTR) has submitted 699+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Strategy's financial statements. The most recent filing was a Form 8-K submitted on May 11, 2026.

Form 4
Strategy Inc Reports Ownership Change on May. 4, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Strategy Files Current Report on May. 11, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Strategy Files Quarterly Report on May. 6, 2026

The 10-Q contains Strategy's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Strategy SEC Filing History

Browse Strategy's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/11/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2026 4:07 PM
Strategy (1050446) Filer
Form DEFA14A
05/06/2026 3:06 PM
Strategy (1050446) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2026 3:46 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2026 2:49 PM
Strategy (1050446) Filer
Form DEFA14A
05/04/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2026 3:28 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2026 12:50 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2026 7:46 AM
Strategy (1050446) Filer
Form DEFA14A
04/30/2026 1:08 PM
Strategy (1050446) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/29/2026 12:12 PM
Strategy (1050446) Filer
Form DEFA14A
04/28/2026 4:14 PM
Strategy (1050446) Filer
Form DEFA14A
04/28/2026 3:44 PM
Strategy (1050446) Filer
Form DEFA14A
04/28/2026 3:04 PM
Strategy (1050446) Filer
Form ARS
04/27/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2026 3:05 PM
Strategy (1050446) Filer
Form DEFA14A
04/23/2026 3:29 PM
Strategy (1050446) Filer
Form DEFA14A
04/22/2026 2:35 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/21/2026 3:04 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/20/2026 1:55 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/20/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 4:24 PM
Strategy (1050446) Filer
Form DEFA14A
04/17/2026 2:58 PM
Strategy (1050446) Filer
Form PRE 14A
04/15/2026 4:44 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2026 3:00 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2026 3:00 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/13/2026 9:54 AM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/13/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2026 3:03 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2026 1:06 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2026 10:00 AM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/07/2026 1:20 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2026 2:32 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2026 3:11 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:44 AM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/30/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2026 12:16 PM
Strategy (1050446) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/26/2026 3:18 PM
Patten Jarrod M (1309191) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2026 7:28 PM
Le Phong (1651669) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2026 7:28 PM
Kang Andrew (1825170) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2026 7:28 PM
Montgomery Jeanine (1444548) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2026 2:58 PM
Le Phong (1651669) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2026 2:28 PM
Kang Andrew (1825170) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/23/2026 8:26 AM
Strategy (1050446) Filer
Form 424B5
03/23/2026 8:31 AM
Strategy (1050446) Filer
Form 424B5
03/23/2026 8:35 AM
Strategy (1050446) Filer
Form 424B5
03/23/2026 8:38 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2026 7:41 AM
Strategy (1050446) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
03/23/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2026 4:39 PM
Kang Andrew (1825170) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2026 4:39 PM
Le Phong (1651669) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2026 4:40 PM
Montgomery Jeanine (1444548) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2026 4:45 PM
Chow Thomas C. (1834012) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2026 3:05 PM
Le Phong (1651669) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 3:05 PM
Kang Andrew (1825170) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 3:05 PM
Montgomery Jeanine (1444548) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 2:30 PM
Le Phong (1651669) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2026 2:23 PM
Kang Andrew (1825170) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/09/2026 6:56 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2026 4:31 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2026 12:39 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2026 2:37 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2026 3:24 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2026 3:17 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2026 4:18 PM
Strategy (1050446) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2026 4:20 PM
Strategy (1050446) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/18/2026 3:12 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/17/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2026 2:25 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2026 8:29 AM
Strategy (1050446) Subject
Form FWP
02/12/2026 2:23 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2026 3:38 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2026 3:38 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2026 3:14 PM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2026 1:15 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2026 2:04 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2026 3:19 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2026 10:27 AM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2026 1:46 PM
Strategy (1050446) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
01/30/2026 8:55 AM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2026 2:02 PM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2026 8:50 AM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/26/2026 9:16 AM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/26/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 9:10 AM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2026 11:20 AM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2026 3:45 PM
Dietze Jane A (1341187) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2026 11:48 AM
Shao Wei-Ming (1663488) Reporting
Strategy (1050446) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2026 3:10 PM
RICKERTSEN CARL J (1203479) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2026 3:38 PM
Le Phong (1651669) Reporting
Strategy (1050446) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 7:00 AM
Strategy (1050446) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Strategy SEC Filings - Frequently Asked Questions

Strategy (MSTR) has submitted 699+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Strategy's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Strategy's financial statements page.

The most recent filing was a Form 8-K submitted on May 11, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:MSTR) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners